secwatch.observer — SEC 8-K summary
======================================

Issuer:     Greenwich LifeSciences, Inc. (GLSI)
CIK:        0001799788
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001493152-24-007223
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Greenwich LifeSciences dismisses MaloneBailey; engages RBSM as new auditor
--------------------------------------------------------------------------

- Audit committee approved dismissal of MaloneBailey and engagement of RBSM on Feb 14, 2024.
- MaloneBailey informed of dismissal effective Feb 15, 2024; RBSM engaged for FY 2023 audit.
- MaloneBailey's reports for 2021-2022 had no adverse opinion, disclaimer, or qualification.
- No disagreements on accounting or audit scope during 2022-2023 or through Feb 14, 2024.
- Material weaknesses in internal control over financial reporting were previously disclosed and discussed with both auditors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799788/000149315224007223/0001493152-24-007223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799788/000149315224007223/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-007223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer